Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127


Hippocampal neurochemical changes in senescent mice induced with chronic injection of D-galactose and NaNO₂: an in vitro high-resolution NMR spectroscopy study at 9.4T.

Lin Y, Yao J, Chen Y, Pang L, Li H, Cao Z, You K, Dai H, Wu R.

PLoS One. 2014 Feb 12;9(2):e88562. doi: 10.1371/journal.pone.0088562. eCollection 2014.


Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.

Chen SQ, Cai Q, Shen YY, Wang PJ, Teng GJ, Zhang W, Zang FC.

Behav Brain Res. 2012 Nov 1;235(1):1-6. doi: 10.1016/j.bbr.2012.07.016. Epub 2012 Jul 22.


Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.

Chen SQ, Wang PJ, Ten GJ, Zhan W, Li MH, Zang FC.

Dement Geriatr Cogn Disord. 2009;28(6):558-66. doi: 10.1159/000261646. Epub 2010 Jan 6.


Proton and phosphorus magnetic resonance spectroscopy of a mouse model of Alzheimer's disease.

Mlynárik V, Cacquevel M, Sun-Reimer L, Janssens S, Cudalbu C, Lei H, Schneider BL, Aebischer P, Gruetter R.

J Alzheimers Dis. 2012;31 Suppl 3:S87-99.


In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity.

Filibian M, Frasca A, Maggioni D, Micotti E, Vezzani A, Ravizza T.

Epilepsia. 2012 Nov;53(11):1907-16. doi: 10.1111/j.1528-1167.2012.03685.x. Epub 2012 Oct 2.


1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages.

Lalande J, Halley H, Balayssac S, Gilard V, Déjean S, Martino R, Francés B, Lassalle JM, Malet-Martino M.

J Alzheimers Dis. 2014;39(1):121-43. doi: 10.3233/JAD-130023.


¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.

Doert A, Pilatus U, Zanella F, Müller WE, Eckert GP.

J Neural Transm (Vienna). 2015 Apr;122(4):541-50. doi: 10.1007/s00702-015-1387-3. Epub 2015 Mar 6.


The effects of aging, housing and ibuprofen treatment on brain neurochemistry in a triple transgene Alzheimer's disease mouse model using magnetic resonance spectroscopy and imaging.

Choi JK, Carreras I, Aytan N, Jenkins-Sahlin E, Dedeoglu A, Jenkins BG.

Brain Res. 2014 Nov 24;1590:85-96. doi: 10.1016/j.brainres.2014.09.067. Epub 2014 Oct 6.


A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 mice.

Jansen D, Zerbi V, Janssen CI, Dederen PJ, Mutsaers MP, Hafkemeijer A, Janssen AL, Nobelen CL, Veltien A, Asten JJ, Heerschap A, Kiliaan AJ.

PLoS One. 2013 May 22;8(5):e63643. doi: 10.1371/journal.pone.0063643. Print 2013.


The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy.

Shiino A, Watanabe T, Shirakashi Y, Kotani E, Yoshimura M, Morikawa S, Inubushi T, Akiguchi I.

J Cereb Blood Flow Metab. 2012 May;32(5):805-15. doi: 10.1038/jcbfm.2012.9. Epub 2012 Feb 8.


Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: an in vivo(1)H-MRS study at 9.4T.

Kim SY, Lee YJ, Kim H, Lee DW, Woo DC, Choi CB, Chae JH, Choe BY.

Brain Res. 2010 Aug 12;1348:105-13. doi: 10.1016/j.brainres.2010.05.097. Epub 2010 Jun 10.


Danggui-Shaoyao-San ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in d-galactose-induced senescent mice.

Lan Z, Liu J, Chen L, Fu Q, Luo J, Qu R, Kong L, Ma S.

J Ethnopharmacol. 2012 May 7;141(1):386-95. doi: 10.1016/j.jep.2012.02.050. Epub 2012 Mar 5.


Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.

Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP.

Neurosci Lett. 2005 Aug 12-19;384(1-2):23-8.


Learning and memory alterations are associated with hippocampal N-acetylaspartate in a rat model of depression as measured by 1H-MRS.

Xi G, Hui J, Zhang Z, Liu S, Zhang X, Teng G, Chan KC, Wu EX, Nie B, Shan B, Li L, Reynolds GP.

PLoS One. 2011;6(12):e28686. doi: 10.1371/journal.pone.0028686. Epub 2011 Dec 14.


Treatment effects in a transgenic mouse model of Alzheimer's disease: a magnetic resonance spectroscopy study after passive immunization.

Marjańska M, Weigand SD, Preboske G, Wengenack TM, Chamberlain R, Curran GL, Poduslo JF, Garwood M, Kobayashi D, Lin JC, Jack CR Jr.

Neuroscience. 2014 Feb 14;259:94-100. doi: 10.1016/j.neuroscience.2013.11.052. Epub 2013 Dec 4.


Anti-inflammatory treatment in AD mice protects against neuronal pathology.

Choi JK, Jenkins BG, Carreras I, Kaymakcalan S, Cormier K, Kowall NW, Dedeoglu A.

Exp Neurol. 2010 Jun;223(2):377-84. doi: 10.1016/j.expneurol.2009.07.032. Epub 2009 Aug 10.


MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes.

Broom KA, Anthony DC, Lowe JP, Griffin JL, Scott H, Blamire AM, Styles P, Perry VH, Sibson NR.

Neurobiol Dis. 2007 Jun;26(3):707-17. Epub 2007 Apr 5.


Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.

Dedeoglu A, Choi JK, Cormier K, Kowall NW, Jenkins BG.

Brain Res. 2004 Jun 25;1012(1-2):60-5.


Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by ¹H MRS in vitro.

Forster DM, James MF, Williams SR.

NMR Biomed. 2012 Jan;25(1):52-8. doi: 10.1002/nbm.1712. Epub 2011 Aug 26.

Items per page

Supplemental Content

Write to the Help Desk